HIGHLIGHTS
- who: Muhammad Yousaf et al. from the Department of Bioinformatics and Biotechnology, Government College University, NICM Health Research Institute, Western Sydney University, Westmead, NSW, Australia have published the Article: Neuroprotection of Cannabidiol, Its Synthetic Derivatives and Combination Preparations against Microglia-Mediated Neuroinflammation in Neurological Disorders, in the Journal: Molecules 2022, 27, x FOR PEER REVIEW of 14/07/2022
- what: This study provides preliminary evidence to support the use of CBD as a preventative therapy for AD to alleviate AD-related symptoms, such as memory loss and behavior disorders, and the mechanism was at least . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.